Allergies News and Research

Latest Allergies News and Research

Infant respiratory syncytial virus infection results in metabolic reprogramming of airway epithelial cells

Infection with respiratory syncytial virus during infancy results in metabolic reprogramming of epithelial cells lining the airway, according to a Northwestern Medicine study published in the journal Viruses.

20 Nov 2021

Researchers receive $22 million grant for clinical trial that aims to reduce lung transplant rejection

Physicians at Washington University School of Medicine in St. Louis and Massachusetts General Hospital/Harvard Medical School in Boston have received a seven-year, $22 million grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to help lead a multicenter clinical trial evaluating whether a novel immunosuppressant can reduce the risk of organ rejection after a lung transplant.

18 Nov 2021

AI and whole genome sequencing improve quick detection of infectious disease outbreaks

By coupling machine learning with whole genome sequencing, University of Pittsburgh School of Medicine and Carnegie Mellon University scientists greatly improved the quick detection of infectious disease outbreaks within a hospital setting over traditional methods for tracking outbreaks.

17 Nov 2021

Lung autopsies provide a clearer picture of how SARS-CoV-2 virus spreads and causes damage

Lung autopsy and plasma samples from people who died of COVID-19 have provided a clearer picture of how the SARS-CoV-2 virus spreads and damages lung tissue.

17 Nov 2021

New guidebook provides a roadmap for navigating the challenges in telehealth

The Foundation for Research Development at the Medical University of South Carolina (MUSC) has partnered with The Stationery Office, a British publishing company, to develop a new guidebook titled TSIM: The Telehealth Framework.

15 Nov 2021

Long-term study begins to evaluate COVID-19's effects on the overall health of children

A large, long-term study of the impacts of COVID-19 on children has enrolled its first participant at the National Institutes of Health's Clinical Center in Bethesda, Maryland.

15 Nov 2021

ACTG announces launch of clinical trial evaluating a three-month TB treatment

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5362 (CLO-FAST), a clinical trial studying a three-month clofazimine- and high-dose rifapentine-containing treatment regimen for people with drug-susceptible tuberculosis (TB).

10 Nov 2021

Western boom cities see spike in harmful ozone

The reduction of harmful ground-level ozone across most of the U.S. over the past several decades has been an air pollution success story.

10 Nov 2021

Scientists create a rapid diagnostic technology to detect SARS-CoV-2

Blending experts from molecular genetics, chemistry and health sciences, researchers at the University of California San Diego have created a rapid diagnostic technology that detects SARS-CoV-2, the coronavirus that causes COVID-19.

6 Nov 2021

Unexpected antibody discovery provides new insight into how the body responds to malaria infection

Malaria, a pathogen transmitted into blood by mosquitoes in tropical climates, is typically thought of as a blood and liver infection.

3 Nov 2021

Research collaboration identifies antibody that limits the severity of coronavirus infections

A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.

2 Nov 2021

Scientists identify compound that shows potential in easing the symptoms of coronavirus infections

By studying a disease caused by a close cousin of the virus behind COVID-19, a team of scientists has identified a compound that shows potential in easing the symptoms of coronavirus infections.

1 Nov 2021

New genetic epidemiology tool provides detailed information about viruses, coinfections

With mask wearing and social distancing on the decline and the cold and flu season upon us, researchers have developed a viral panel that enables the simultaneous testing for SARS-CoV-2 along with numerous common respiratory viruses, that tells us whether other viruses also are at play in patients hard hit by COVID.

1 Nov 2021

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.

1 Nov 2021

Prompt procurement and rapid pace of vaccination likely to have a greater impact than vaccine efficacy

For low- and middle-income countries, a COVID-19 vaccination program built on prompt procurement, effective on-the-ground distribution, and a rapid pace of vaccination (the total number of doses given daily) is likely to have a greater public health impact than one focused on relatively small differences in vaccine efficacy, according to a study led by researchers at Massachusetts General Hospital.

30 Oct 2021

NIH study identifies distinct mechanisms of long-term HIV control in two people after treatment disruption

Research led by scientists at the National Institutes of Health has identified two distinct ways that people with HIV can control the virus for an extended period after stopping antiretroviral therapy (ART) under medical supervision.

29 Oct 2021

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

Kawasaki disease (KD) is rare, with fewer than 6,000 diagnosed cases per year in the United States. It is most common in infants and young children and causes inflammation in the walls of some blood vessels in the body.

27 Oct 2021

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Researchers in the United States have conducted a study showing that Moderna’s coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.

26 Oct 2021

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

In the worldwide effort to battle SARS-CoV-2, the virus that causes COVID-19, researchers have often turned to medications used as therapies for other conditions in the hopes of finding ones that either kill the coronavirus or lessen the impacts from its infection.

26 Oct 2021

NIH invests $74.5 million to advance data science research and spur health discoveries across Africa

The National Institutes of Health is investing about $74.5 million over five years to advance data science, catalyze innovation and spur health discoveries across Africa.

26 Oct 2021

Allergies News and Research

Latest Allergies News and Research

Infant respiratory syncytial virus infection results in metabolic reprogramming of airway epithelial cells

Researchers receive $22 million grant for clinical trial that aims to reduce lung transplant rejection

AI and whole genome sequencing improve quick detection of infectious disease outbreaks

Lung autopsies provide a clearer picture of how SARS-CoV-2 virus spreads and causes damage

New guidebook provides a roadmap for navigating the challenges in telehealth

Long-term study begins to evaluate COVID-19's effects on the overall health of children

ACTG announces launch of clinical trial evaluating a three-month TB treatment

Western boom cities see spike in harmful ozone

Scientists create a rapid diagnostic technology to detect SARS-CoV-2

Unexpected antibody discovery provides new insight into how the body responds to malaria infection

Research collaboration identifies antibody that limits the severity of coronavirus infections

Scientists identify compound that shows potential in easing the symptoms of coronavirus infections

New genetic epidemiology tool provides detailed information about viruses, coinfections

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

Prompt procurement and rapid pace of vaccination likely to have a greater impact than vaccine efficacy

NIH study identifies distinct mechanisms of long-term HIV control in two people after treatment disruption

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

NIH invests $74.5 million to advance data science research and spur health discoveries across Africa

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Allergies News and Research

Latest Allergies News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in